Position in ZTS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$8,838
-$16,577 QoQ
Shares Held
123
-42.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,252
of 1,408 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Frazier Financial Advisors, LLC holds $20,635 across 2 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (42.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
70 | $11,797 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
123 | $8,838 |
All Filings in ZTS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,838 | 123 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $25,415 | 215 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $27,051 | 215 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $31,458 | 215 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $35,712 | 229 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $37,704 | 229 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $37,310 | 229 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $44,742 | 229 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $41,259 | 238 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $55,839 | 330 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $63,553 | 322 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||